🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Aptevo Therapeutics Inc.
APVO436
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company specializing in the development of immunotherapeutic candidates to treat various forms of cancer, with a primary focus on APVO436, a bispecific T-cell engaging antibody for leukemia and myelodysplastic syndrome.
About | Leadership | Directors | About | Contact | About | Contact | Contact | Contact | About | Leadership | Directors | About | About | About | About | About | About | About | About | About | About | About
Symbol: APVO
Recent Price: $4.78
Industry: Biotechnology
CEO: Mr. Marvin L. White
Sector: Healthcare
Employees: 40
Address: 2401 4th Avenue, Seattle, WA 98121
Phone: 206 838 0500
Leadership
- Marvin L. White, President and Chief Executive Officer
- Jeff Lamothe, EVP and Chief Operating Officer
- Daphne Taylor, SVP and Chief Financial Officer
- Dirk Huebner, M.D., Chief Medical Officer
- SoYoung Kwon, SVP, General Counsel, Business Development and Corporate Affairs
Last updated: 2024-12-31